1. Home
  2. VRTX vs LOW Comparison

VRTX vs LOW Comparison

Compare VRTX & LOW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vertex Pharmaceuticals Incorporated

VRTX

Vertex Pharmaceuticals Incorporated

N/A

Current Price

$517.10

Market Cap

135.6B

Sector

Technology

ML Signal

N/A

Logo Lowe's Companies Inc.

LOW

Lowe's Companies Inc.

N/A

Current Price

$221.89

Market Cap

122.4B

ML Signal

N/A

Company Overview

Basic Information
Metric
VRTX
LOW
Founded
1989
1946
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
RETAIL: Building Materials
Sector
Technology
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
135.6B
122.4B
IPO Year
2007
1994

Fundamental Metrics

Financial Performance
Metric
VRTX
LOW
Price
$517.10
$221.89
Analyst Decision
Buy
Buy
Analyst Count
32
35
Target Price
★ $595.36
$249.48
AVG Volume (30 Days)
1.3M
★ 2.9M
Earning Date
11-02-2026
11-18-2026
Dividend Yield
N/A
★ 2.28%
EPS Growth
★ 836.54
N/A
EPS
★ 10.90
7.17
Revenue
$2,488,652,000.00
★ $86,286,000,000.00
Revenue This Year
$10.46
$7.05
Revenue Next Year
$10.53
$2.12
P/E Ratio
$47.77
★ $30.56
Revenue Growth
★ 46.20
3.12
52 Week Low
$412.27
$178.45
52 Week High
$568.67
$293.06

Technical Indicators

Market Signals
Indicator
VRTX
LOW
Relative Strength Index (RSI) 41.75 56.69
Support Level $493.75 $203.60
Resistance Level $536.58 $224.43
Average True Range (ATR) 15.90 6.39
MACD -3.73 -1.34
Stochastic Oscillator 4.74 42.00

Price Performance

Historical Comparison
VRTX
LOW

About VRTX Vertex Pharmaceuticals Incorporated

Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio, and Alyftrek for cystic fibrosis, where Vertex therapies remain the standard of care globally. Vertex is focused on diversifying its portfolio through Casgevy (gene-editing therapy for beta thalassemia and sickle-cell disease), Journavx (non-opioid pain drug for moderate-to-severe acute pain), and Palsonify (for acromegaly). Additionally, Vertex is evaluating small-molecule inhibitors of APOL1-mediated kidney diseases, cell therapies to deliver a functional cure for type 1 diabetes, povetacicept (for IgA nephropathy).

About LOW Lowe's Companies Inc.

Lowe's is the second-largest home improvement retailer globally, with 1,761 stores in the US, after the 2023 divestiture of its Canadian locations. The firm's stores offer products and services for home decorating, maintenance, repair, and remodeling, with maintenance and repair accounting for two-thirds of products sold. Lowe's primarily targets retail do-it-yourself (more than 60% of sales) and do-it-for-me customers, but has expanded its professional business clients to more than 30% from less than 20% in the past seven years (set to expand further with growth of FBM locations). We estimate Lowe's captures a high-single-digit share of the domestic home improvement market, based on US Census data and management's market size estimates.

Share on Social Networks: